Enanta Pharmaceuticals prices public offering of 6.5M shares at $10/share, expects ~$60.6M net proceeds

ENANTA PHARMACEUTICALS INC

6,500,000 shares offered at $10.00 per share; underwriters have 30-day option for 975,000 more shares.
Expected net proceeds of approximately $60.6 million after underwriting discounts and offering expenses.
Offering expected to close on October 2, 2025, subject to customary closing conditions.
Underwriting agreement with J.P. Morgan, Jefferies, and Evercore dated September 30, 2025.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.